Evidence map›Paper›PMID 26882560›Full record

ArticleEMBO reports2016

The translational relevance of Drosophila in drug discovery.

Ismael Fernández-Hernández, Eulalia Scheenaard, Giulia Pollarolo, Cayetano Gonzalez

Abstract read
In one paragraph

Article in EMBO reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. A Drosophila Study Model for EWS::FLI1-Induced Molecular Pathways.Methods in molecular biology (Clifton, N.J.) · 2027
    Article
  2. A Landscape ofBiology · 2026
    Review
  3. Review
  4. Pharmacology of Aging:Aging biology · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Fruit fly for anticancer drug discovery and repurposing.Annals of medicine and surgery (2012) · 2023
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Mechanosensory neuron regeneration in adultDevelopment (Cambridge, England) · 2021
    Article
  16. Exploiting the Potential ofBiomedicines · 2021
    Review
  17. Review
  18. The Nitric Oxide Donor,Frontiers in cell and developmental biology · 2021
    Article
  19. Frontiers in physiology · 2021
    Review
  20. Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ismael Fernández-HernándezCell Division Group, Institute for Research in Biomedicine (IRB Barcelona) The Barcelona Institute of Science and Technology, Barcelona, Spain.
Eulalia ScheenaardCell Division Group, Institute for Research in Biomedicine (IRB Barcelona) The Barcelona Institute of Science and Technology, Barcelona, Spain.
Giulia PollaroloCell Division Group, Institute for Research in Biomedicine (IRB Barcelona) The Barcelona Institute of Science and Technology, Barcelona, Spain.
Cayetano GonzalezCell Division Group, Institute for Research in Biomedicine (IRB Barcelona) The Barcelona Institute of Science and Technology, Barcelona, Spain Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DrosophilaDrug DiscoveryModels, AnimalTranslational Research, BiomedicalAnimalsDrosophila ProteinsHumansProteomicsDrosophila Proteins

Identifiers

PMID26882560
PMCPMC4818774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.